Uncategorized

This project has been funded in whole or in part with Federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority, under Contract No. 75A50122C00067

Dr Tara Dalton will be presenting Altratech's technology and assay at the World Home Diagnostics Summit in San Diego on November 30th.

At NextGenDx conference (Aug 2022), Altratech presented "Enabling Point-of-Care Diagnostics"

Altratech is developing a portable RNA kit, a device capable of diagnosing viruses such as HIV, Ebola and zika without the need for a lab.

At NextGenDx conference (Aug 2020), Altratech presented “Novel Techniques for POC Disease Monitoring Utilizing Programmable Molecular Velcro” These advanced PNA probes were co-developed by Altratech and NIH, and jointly filed in a US patent disclosure

MedTech Innovator Selects 50 Best-in-Class Startups for 2019 Showcase and Accelerator

PNA probes have different design rules to other oligomer probes. Altratech has developed a PNA-probe design tool “ROCAP” and launched it today at Medica 2018. It is in beta use at Altratech, at partners, and at NIH in US

Limerick-based Altratech has raised €5.2m after Bank of Ireland's Kernel Capital Growth Fund and Infinity Capital led a €2.2m investment, while the company also secured €3m in EU Horizon 2020 funding. Altratech is developing a single-use portable semiconductor test kit for "point of care" testing of infectious viral diseases. Its Read More

A SHANNON company is set to receive a share of €10 million in funding from the EU’s scientific research fund. AltraTech has been named among five small Irish companies with big ideas awarded with the funding to help get their ideas to market. The company has developed a portable battery-operated Read More